Literature DB >> 6104477

Reduction of cerebrospinal fluid glutamic acid in Huntington's chorea and in schizophrenic patients.

J S Kim, H H Kornhuber, B Holzmüller, W Schmid-Burgk, T Mergner, G Krzepinski.   

Abstract

Glutamic acid levels were investigated in the cerebrospinal fluid and blood serum of patients with schizophrenia, Huntington's chorea, and sciatic nerve compression by lumbar disc protrusion. In the serum the glutamic acid levels were equal in all three groups; in the cerebrospinal fluid (CSF) of schizophrenic and Hungtington's patients, however, the glutamic acid was decreased to almost half that of the lumbar disc group which served as control. Most of the patients were treated with neuroleptic drugs. However, since in one case (the daughter of a Huntington's patient) the CSF glutamic acid was decreased although this woman had had no neuroleptic treatment, it seems more likely that the glutamic acid decrease is due to the disease rather than to the neuroleptic treatment.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6104477     DOI: 10.1007/bf00365738

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  3 in total

1.  Evidence for a hippocampal-septal glutamatergic pathway in the rat.

Authors:  R Zaczek; J C Hedreen; J T Coyle
Journal:  Exp Neurol       Date:  1979-07       Impact factor: 5.330

2.  Effect of frontal cortex ablation on striatal glutamic acid level in rat.

Authors:  J S Kim; R Hasller; P Hau; K S Paik
Journal:  Brain Res       Date:  1977-08-26       Impact factor: 3.252

3.  Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods.

Authors:  L T Graham; M H Aprison
Journal:  Anal Biochem       Date:  1966-06       Impact factor: 3.365

  3 in total
  8 in total

1.  Harnessing the power of yeast to elucidate the role of sphingolipids in metabolic and signaling processes pertinent to psychiatric disorders.

Authors:  Shyamalagauri Jadhav; Miriam L Greenberg
Journal:  Clin Lipidol       Date:  2014-11-01

2.  Huntington's disease - imbalance of free amino acids in the cerebrospinal fluid of patients and offspring at-risk.

Authors:  G Oepen; H Cramer; R Bernasconi; P Martin
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

Review 3.  Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.

Authors:  Kenji Hashimoto; Berend Malchow; Peter Falkai; Andrea Schmitt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-01       Impact factor: 5.270

Review 4.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

5.  Systematic analysis of transcription-level effects of neurodegenerative diseases on human brain metabolism by a newly reconstructed brain-specific metabolic network.

Authors:  Mustafa Sertbaş; Kutlu Ulgen; Tunahan Cakır
Journal:  FEBS Open Bio       Date:  2014-06-06       Impact factor: 2.693

6.  Impact of plasma transaminase levels on the peripheral blood glutamate levels and memory functions in healthy subjects.

Authors:  Yoshihiro Kamada; Ryota Hashimoto; Hidenaga Yamamori; Yuka Yasuda; Tetsuo Takehara; Yuko Fujita; Kenji Hashimoto; Eiji Miyoshi
Journal:  BBA Clin       Date:  2016-02-23

Review 7.  Overview of Glutamatergic Dysregulation in Central Pathologies.

Authors:  Tanya Miladinovic; Mina G Nashed; Gurmit Singh
Journal:  Biomolecules       Date:  2015-11-11

8.  Glycine-Binding Site Stimulants of NMDA Receptors Alleviate Extrapyramidal Motor Disorders by Activating the Nigrostriatal Dopaminergic Pathway.

Authors:  Saki Shimizu; Shunsaku Sogabe; Ryoto Yanagisako; Akiyoshi Inada; Megumi Yamanaka; Higor A Iha; Yukihiro Ohno
Journal:  Int J Mol Sci       Date:  2017-07-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.